Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | 7.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 0.52 | (0.45) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 0.22 | (0.95) | (1.36)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 0.54 | (2.70) | (2.61)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 0.59 | (3.12) | (3.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (1.45) | (0.12)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Raises £1.25 Million to Accelerate Programmes | 16-Oct-2025 | 07:00 | RNS |
| Half-year Report | 30-Sep-2025 | 07:00 | RNS |
| Solvonis secures exclusive CNS collaboration | 28-Aug-2025 | 07:00 | RNS |
| Graft Polymer to buy Awakn in £4.98m deal | 16-Dec-2024 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.34p |
| Change Today | 0.020p |
| % Change | 6.25 % |
| 52 Week High | 0.39 |
| 52 Week Low | 0.12 |
| Volume | 30,223,132 |
| Shares Issued | 6,783m |
| Market Cap | £23.06m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 17:08 | 1,000,000 @ 0.34p |
| 16:38 | 1,000,000 @ 0.34p |
| 16:22 | 362,951 @ 0.33p |
| 15:51 | 71,472 @ 0.34p |
| 15:28 | 6,549 @ 0.34p |
| CEO | Anthony Tennyson |
| Chair | Dennis Purcell |
| Finance Director | Ryan Neats |
You are here: research